+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Human Papillomavirus"

From
From
From
From
From
Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 116 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Human Papillomavirus (HPV) is a virus that can cause a variety of cancers, including cervical, anal, and oropharyngeal cancers. In the oncology market, HPV-related treatments are used to treat these cancers, as well as to prevent them from occurring in the first place. HPV vaccines are used to prevent infection with the virus, while treatments such as chemotherapy and radiation therapy are used to treat HPV-related cancers. Additionally, targeted therapies such as immunotherapy and monoclonal antibodies are used to treat HPV-related cancers. In the HPV market, there are a number of companies that are involved in the development and manufacture of treatments and vaccines. These include Merck, GlaxoSmithKline, Sanofi, Pfizer, and AstraZeneca. Additionally, there are a number of smaller companies that are involved in the development of treatments and vaccines for HPV-related cancers. Show Less Read more